{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:12:55Z","timestamp":1791267175396,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03923-6","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T05:26:38Z","timestamp":1766553998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Assessment of neuroprotective efficacy of N-acetylcysteine compared with brimonidine in an experimental glaucoma model"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8113-8591","authenticated-orcid":false,"given":"Mustafa","family":"Yavuz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4956-3774","authenticated-orcid":false,"given":"Semra","family":"Acer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9262-996X","authenticated-orcid":false,"given":"Omer","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6877-4884","authenticated-orcid":false,"given":"Mehmet","family":"Argun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1835-1082","authenticated-orcid":false,"given":"Ozlem","family":"Ozmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0819-915X","authenticated-orcid":false,"given":"Levent","family":"Tok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"16","key":"3923_CR1","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1001\/jama.2023.16311","volume":"330","author":"R Voelker","year":"2023","unstructured":"Voelker R (2023) What Is Glaucoma? JAMA 330(16):1594","journal-title":"JAMA"},{"issue":"2","key":"3923_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/OPX.0000000000001183","volume":"95","author":"MD Twa","year":"2018","unstructured":"Twa MD (2018) Intraocular pressure and glaucoma. Optom Vis Sci 95(2):83\u201385","journal-title":"Optom Vis Sci"},{"issue":"2","key":"3923_CR3","doi-asserted-by":"publisher","first-page":"380","DOI":"10.4103\/ijo.IJO_1158_21","volume":"70","author":"CR Vishwaraj","year":"2022","unstructured":"Vishwaraj CR, Kavitha S, Venkatesh R et al (2022) Neuroprotection in glaucoma. Indian J Ophthalmol 70(2):380\u2013385","journal-title":"Indian J Ophthalmol"},{"key":"3923_CR4","first-page":"92","volume":"1","author":"JR Tribble","year":"2023","unstructured":"Tribble JR, Hui F, Quintero H et al (2023) Neuroprotection in glaucoma: Mechanisms beyond intraocular pressure lowering. Mol Aspects Med 1:92","journal-title":"Mol Aspects Med"},{"issue":"257","key":"3923_CR5","first-page":"155","volume":"1","author":"D Scuteri","year":"2020","unstructured":"Scuteri D, Bagetta G, Nucci C et al (2020) Evidence on the neuroprotective properties of brimonidine in glaucoma. Prog Brain Res 1(257):155\u2013166","journal-title":"Prog Brain Res"},{"issue":"2","key":"3923_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2165\/00003088-199120020-00004","volume":"20","author":"MR Holdiness","year":"1991","unstructured":"Holdiness MR (1991) Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet 20(2):123\u2013134","journal-title":"Clin Pharmacokinet"},{"key":"3923_CR7","doi-asserted-by":"crossref","unstructured":"Ten\u00f3rio MCDS, Graciliano NG, Moura FA, et al. (2021) N-Acetylcysteine (NAC): Impacts on Human Health. Antioxidants (Basel). 10(6)","DOI":"10.3390\/antiox10060967"},{"issue":"8","key":"3923_CR8","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.2174\/1570159X19666201230144109","volume":"19","author":"G Raghu","year":"2021","unstructured":"Raghu G, Berk M, Campochiaro PA et al (2021) The multifaceted therapeutic role of n-acetylcysteine (NAC) in disorders characterized by oxidative stress. Curr Neuropharmacol 19(8):1202\u20131224","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"3923_CR9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/14734220601142878","volume":"6","author":"M Arakawa","year":"2007","unstructured":"Arakawa M, Ito Y (2007) N-acetylcysteine and neurodegenerative diseases: basic and clinical pharmacology. Cerebellum 6(4):308","journal-title":"Cerebellum"},{"issue":"1750","key":"3923_CR10","volume":"15","author":"ME Hubbard","year":"2021","unstructured":"Hubbard ME, Sprague S, Boileau AJ et al (2021) N-acetylcysteine improves behavioral outcomes after experimental traumatic brain injury. Brain Res 15(1750):147163","journal-title":"Brain Res"},{"issue":"12","key":"3923_CR11","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.18240\/ijo.2021.12.01","volume":"14","author":"SB Hwang","year":"2021","unstructured":"Hwang SB, Park JH, Park JY et al (2021) Anti-inflammatory and anti-apoptotic effects of N-acetylcysteine in diabetic rat corneal epithelium. Int J Ophthalmol 14(12):1805\u20131812","journal-title":"Int J Ophthalmol"},{"issue":"7","key":"3923_CR12","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/jcp.22508","volume":"226","author":"SY Lee","year":"2011","unstructured":"Lee SY, Usui S, Zafar A et al (2011) N-Acetylcysteine promotes long-term survival of cones in a model of retinitis pigmentosa. J Cell Physiol 226(7):1843\u20131849","journal-title":"J Cell Physiol"},{"issue":"2","key":"3923_CR13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.survophthal.2021.07.008","volume":"67","author":"Y Eghtedari","year":"2022","unstructured":"Eghtedari Y, Oh LJ, Di GN et al (2022) The role of topical N-acetylcysteine in ocular therapeutics. Surv Ophthalmol 67(2):608\u2013622","journal-title":"Surv Ophthalmol"},{"key":"3923_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5174957","author":"MR Terluk","year":"2019","unstructured":"Terluk MR, Ebeling MC, Fisher CR et al (2019) N-acetyl-L-cysteine protects human retinal pigment epithelial cells from oxidative damage: implications for age-related macular degeneration. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2019\/5174957","journal-title":"Oxid Med Cell Longev"},{"key":"3923_CR15","first-page":"50","volume":"50","author":"Z Tang","year":"2011","unstructured":"Tang Z, Zhang S, Lee C et al (2011) An optic nerve crush injury murine model to study retinal ganglion cell survival. J Vis Exp 50:50","journal-title":"J Vis Exp"},{"issue":"2","key":"3923_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351\u2013358","journal-title":"Anal Biochem"},{"issue":"1","key":"3923_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82(1):70\u201377","journal-title":"Arch Biochem Biophys"},{"issue":"12","key":"3923_CR18","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.clinbiochem.2005.08.008","volume":"38","author":"O Erel","year":"2005","unstructured":"Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38(12):1103\u20131111","journal-title":"Clin Biochem"},{"issue":"2","key":"3923_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.clinbiochem.2003.10.014","volume":"37","author":"O Erel","year":"2004","unstructured":"Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37(2):112\u2013119","journal-title":"Clin Biochem"},{"issue":"2","key":"3923_CR20","first-page":"121","volume":"32","author":"DJ Calkins","year":"2021","unstructured":"Calkins DJ (2021) Neuroprotection in glaucoma: recent developments and future directions. Curr Opin Ophthalmol 32(2):121\u2013128","journal-title":"Curr Opin Ophthalmol"},{"key":"3923_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/716458","author":"G Chen","year":"2008","unstructured":"Chen G, Shi J, Hu Z et al (2008) Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: a potential neuroprotective mechanism of N-acetylcysteine. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2008\/716458","journal-title":"Mediators Inflamm"},{"issue":"5","key":"3923_CR22","first-page":"375","volume":"11","author":"O Cakir","year":"2003","unstructured":"Cakir O (2003) Neuroprotective effect of N-acetylcysteine and hypothermia on the spinal cord ischemia\u2013reperfusion injury. Cardiovasc Surg 11(5):375\u2013379","journal-title":"Cardiovasc Surg"},{"issue":"5","key":"3923_CR23","doi-asserted-by":"publisher","first-page":"1105e","DOI":"10.1097\/PRS.0000000000003257","volume":"139","author":"J Catapano","year":"2017","unstructured":"Catapano J, Zhang J, Scholl D et al (2017) N-acetylcysteine prevents retrograde motor neuron death after neonatal peripheral nerve injury. Plast Reconstr Surg 139(5):1105e-e1115","journal-title":"Plast Reconstr Surg"},{"issue":"75","key":"3923_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.100799","volume":"1","author":"IH Pang","year":"2020","unstructured":"Pang IH, Clark AF (2020) Inducible Rodent Models of Glaucoma. Prog Retin Eye Res 1(75):100799","journal-title":"Prog Retin Eye Res"},{"key":"3923_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-6-4","author":"WS Lambert","year":"2011","unstructured":"Lambert WS, Ruiz L, Crish SD et al (2011) Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons. Mol Neurodegener. https:\/\/doi.org\/10.1186\/1750-1326-6-4","journal-title":"Mol Neurodegener"},{"issue":"16","key":"3923_CR26","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1089\/ars.2020.8180","volume":"35","author":"AH Jassim","year":"2021","unstructured":"Jassim AH, Fan Y, Pappenhagen N et al (2021) Oxidative stress and hypoxia modify mitochondrial homeostasis during glaucoma. Antioxid Redox Signal 35(16):1341\u20131357","journal-title":"Antioxid Redox Signal"},{"key":"3923_CR27","unstructured":"Tatton WG, Chalmers-Redman RME, Tatton NA (2001) Apoptosis and anti-apoptosis signalling in glaucomatous retinopathy. Eur J Ophthalmol. 11 Suppl 2(SUPPL. 2):S12\u201322"},{"key":"3923_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2025.120248","volume":"572","author":"L Agnello","year":"2025","unstructured":"Agnello L, Gambino CM, Ciaccio AM et al (2025) The value of serum glial fibrillary acidic protein as a biomarker of astrogliosis in different neurological diseases. Clin Chim Acta 572:120248","journal-title":"Clin Chim Acta"},{"key":"3923_CR29","first-page":"223","volume":"1","author":"CA Girkin","year":"2024","unstructured":"Girkin CA, Strickland RG, Somerville MM et al (2024) Acute ocular hypertension in the living human eye: Model description and initial cellular responses to elevated intraocular pressure. Vision Res 1:223","journal-title":"Vision Res"},{"key":"3923_CR30","doi-asserted-by":"crossref","unstructured":"Yabana T, Sato K, Shiga Y, et al. (2019) The relationship between glutathione levels in leukocytes and ocular clinical parameters in glaucoma. PLoS One. 14(12)","DOI":"10.1371\/journal.pone.0227078"},{"key":"3923_CR31","doi-asserted-by":"crossref","unstructured":"Lu B, Wang X, Ren Z, et al. (2020) Anti-glaucoma potential of hesperidin in experimental glaucoma induced rats. AMB Express. 10(1)","DOI":"10.1186\/s13568-020-01027-1"},{"issue":"9","key":"3923_CR32","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/IJG.0b013e31819c46b1","volume":"18","author":"G Ozdemir","year":"2009","unstructured":"Ozdemir G, Tolun FI, Gul M et al (2009) Retinal oxidative stress induced by intraocular hypertension in rats may be ameliorated by brimonidine treatment and n-acetyl cysteine supplementation. J Glaucoma 18(9):662\u2013665","journal-title":"J Glaucoma"},{"key":"3923_CR33","doi-asserted-by":"crossref","unstructured":"Sato K, Saigusa D, Kokubun T, et al. (2023) Reduced glutathione level in the aqueous humor of patients with primary open-angle glaucoma and normal-tension glaucoma. npj aging 9(1)","DOI":"10.1038\/s41514-023-00124-2"},{"issue":"1","key":"3923_CR34","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12871-021-01516-1","volume":"21","author":"C Bin","year":"2021","unstructured":"Bin C, Xiaohui W, Mengrou S et al (2021) Preliminary evaluation of the efficacy and safety of brimonidine for general anesthesia. BMC Anesthesiol 21(1):305","journal-title":"BMC Anesthesiol"},{"issue":"6","key":"3923_CR35","volume":"16","author":"F Gul","year":"2024","unstructured":"Gul F, Shah M, Waqar M et al (2024) Severe central nervous system and respiratory depression in a neonate following accidental oral ingestion of brimonidine tartrate. Cureus 16(6):e63124","journal-title":"Cureus"},{"issue":"8","key":"3923_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0308671","volume":"19","author":"R Maciulaitiene","year":"2024","unstructured":"Maciulaitiene R, Kalesnykas G, Pauza DH et al (2024) A combination of topical and systemic administration of brimonidine is neuroprotective in the murine optic nerve crush model. PLoS ONE 19(8):e0308671","journal-title":"PLoS ONE"},{"issue":"5","key":"3923_CR37","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.parkreldis.2015.02.020","volume":"21","author":"M Katz","year":"2015","unstructured":"Katz M, Won SJ, Park Y et al (2015) Cerebrospinal fluid concentrations of N-acetylcysteine after oral administration in Parkinson\u2019s disease. Parkinsonism Relat Disord 21(5):500\u2013503","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"3923_CR38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/pharmrev.120.000056","volume":"73","author":"Y Samuni","year":"2021","unstructured":"Samuni Y, Goldstein S, Dean OM et al (2021) N-acetylcysteine: A safe and effective bioactive compound with potential applications in treating psychiatric disorders and reducing oxidative stress. Pharmacol Rev 73(1):202\u2013228","journal-title":"Pharmacol Rev"},{"issue":"3","key":"3923_CR39","first-page":"215","volume":"23","author":"KD Frick","year":"2021","unstructured":"Frick KD, Kitzmiller JP, Levin AV (2021) Systemic side effects of ophthalmic drops in children: a review. Pediatr Drugs 23(3):215\u2013226","journal-title":"Pediatr Drugs"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03923-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03923-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03923-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T05:26:41Z","timestamp":1766554001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03923-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3923"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03923-6","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experimental procedures were performed in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. This study was approved by the Mehmet Akif Ersoy University Animal Experiments Local Ethics Committee (Approval No: 1.337, Date: 18.07.2024).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable. This study did not involve human participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable. This study did not include any individual person\u2019s data in any form.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"53"}}